nodes	percent_of_prediction	percent_of_DWPC	metapath
Dofetilide—Infarction—Sorafenib—thyroid cancer	0.062	0.0663	CcSEcCtD
Dofetilide—Cerebral ischaemia—Vandetanib—thyroid cancer	0.0528	0.0564	CcSEcCtD
Dofetilide—Sudden death—Vandetanib—thyroid cancer	0.0498	0.0533	CcSEcCtD
Dofetilide—Torsade de pointes—Vandetanib—thyroid cancer	0.0364	0.0389	CcSEcCtD
Dofetilide—Ventricular arrhythmia—Vandetanib—thyroid cancer	0.0345	0.0368	CcSEcCtD
Dofetilide—Rosiglitazone—PPARG—thyroid cancer	0.0308	1	CrCbGaD
Dofetilide—Cardiac failure—Vandetanib—thyroid cancer	0.019	0.0203	CcSEcCtD
Dofetilide—Cardiac arrest—Vandetanib—thyroid cancer	0.0176	0.0188	CcSEcCtD
Dofetilide—Influenza—Vandetanib—thyroid cancer	0.016	0.0171	CcSEcCtD
Dofetilide—Urinary tract infection—Vandetanib—thyroid cancer	0.0139	0.0148	CcSEcCtD
Dofetilide—Bradycardia—Vandetanib—thyroid cancer	0.013	0.0139	CcSEcCtD
Dofetilide—Cardiac failure—Sorafenib—thyroid cancer	0.0128	0.0137	CcSEcCtD
Dofetilide—Bundle branch block—Epirubicin—thyroid cancer	0.0126	0.0135	CcSEcCtD
Dofetilide—Bundle branch block—Doxorubicin—thyroid cancer	0.0117	0.0125	CcSEcCtD
Dofetilide—Arrhythmia—Vandetanib—thyroid cancer	0.0114	0.0122	CcSEcCtD
Dofetilide—KCNJ12—thyroid gland—thyroid cancer	0.011	0.327	CbGeAlD
Dofetilide—Loss of consciousness—Vandetanib—thyroid cancer	0.0098	0.0105	CcSEcCtD
Dofetilide—KCNJ12—head—thyroid cancer	0.00979	0.29	CbGeAlD
Dofetilide—Cough—Vandetanib—thyroid cancer	0.00973	0.0104	CcSEcCtD
Dofetilide—Hypertension—Vandetanib—thyroid cancer	0.00963	0.0103	CcSEcCtD
Dofetilide—Chest pain—Vandetanib—thyroid cancer	0.00949	0.0101	CcSEcCtD
Dofetilide—Arthralgia—Vandetanib—thyroid cancer	0.00949	0.0101	CcSEcCtD
Dofetilide—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00949	0.0101	CcSEcCtD
Dofetilide—Anxiety—Vandetanib—thyroid cancer	0.00946	0.0101	CcSEcCtD
Dofetilide—Myocardial infarction—Sorafenib—thyroid cancer	0.00943	0.0101	CcSEcCtD
Dofetilide—Paralysis—Epirubicin—thyroid cancer	0.00915	0.00978	CcSEcCtD
Dofetilide—Oedema—Vandetanib—thyroid cancer	0.0091	0.00973	CcSEcCtD
Dofetilide—Ventricular arrhythmia—Epirubicin—thyroid cancer	0.00859	0.00918	CcSEcCtD
Dofetilide—Paralysis—Doxorubicin—thyroid cancer	0.00847	0.00905	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00829	0.00886	CcSEcCtD
Dofetilide—Insomnia—Vandetanib—thyroid cancer	0.00823	0.0088	CcSEcCtD
Dofetilide—Paraesthesia—Vandetanib—thyroid cancer	0.00817	0.00873	CcSEcCtD
Dofetilide—Dyspnoea—Vandetanib—thyroid cancer	0.00811	0.00867	CcSEcCtD
Dofetilide—Ventricular arrhythmia—Doxorubicin—thyroid cancer	0.00795	0.0085	CcSEcCtD
Dofetilide—Pain—Vandetanib—thyroid cancer	0.00778	0.00832	CcSEcCtD
Dofetilide—Arrhythmia—Sorafenib—thyroid cancer	0.00772	0.00825	CcSEcCtD
Dofetilide—Liver injury—Epirubicin—thyroid cancer	0.00756	0.00808	CcSEcCtD
Dofetilide—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00744	0.00795	CcSEcCtD
Dofetilide—Abdominal pain—Vandetanib—thyroid cancer	0.00719	0.00769	CcSEcCtD
Dofetilide—Liver injury—Doxorubicin—thyroid cancer	0.00699	0.00747	CcSEcCtD
Dofetilide—Cough increased—Epirubicin—thyroid cancer	0.00695	0.00742	CcSEcCtD
Dofetilide—Angioedema—Sorafenib—thyroid cancer	0.00687	0.00735	CcSEcCtD
Dofetilide—Syncope—Sorafenib—thyroid cancer	0.00674	0.00721	CcSEcCtD
Dofetilide—Loss of consciousness—Sorafenib—thyroid cancer	0.00661	0.00707	CcSEcCtD
Dofetilide—Cough—Sorafenib—thyroid cancer	0.00656	0.00702	CcSEcCtD
Dofetilide—Atrioventricular block—Epirubicin—thyroid cancer	0.00656	0.00701	CcSEcCtD
Dofetilide—Asthenia—Vandetanib—thyroid cancer	0.00653	0.00698	CcSEcCtD
Dofetilide—Hypertension—Sorafenib—thyroid cancer	0.00649	0.00694	CcSEcCtD
Dofetilide—Cough increased—Doxorubicin—thyroid cancer	0.00643	0.00687	CcSEcCtD
Dofetilide—Arthralgia—Sorafenib—thyroid cancer	0.0064	0.00684	CcSEcCtD
Dofetilide—Hepatocellular injury—Epirubicin—thyroid cancer	0.00636	0.0068	CcSEcCtD
Dofetilide—Ventricular tachycardia—Epirubicin—thyroid cancer	0.00636	0.0068	CcSEcCtD
Dofetilide—KCNK2—thyroid gland—thyroid cancer	0.0063	0.187	CbGeAlD
Dofetilide—Diarrhoea—Vandetanib—thyroid cancer	0.00623	0.00666	CcSEcCtD
Dofetilide—Atrioventricular block—Doxorubicin—thyroid cancer	0.00607	0.00648	CcSEcCtD
Dofetilide—Shock—Sorafenib—thyroid cancer	0.00604	0.00646	CcSEcCtD
Dofetilide—Dizziness—Vandetanib—thyroid cancer	0.00602	0.00643	CcSEcCtD
Dofetilide—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.00588	0.00629	CcSEcCtD
Dofetilide—Hepatocellular injury—Doxorubicin—thyroid cancer	0.00588	0.00629	CcSEcCtD
Dofetilide—Rash—Vandetanib—thyroid cancer	0.00574	0.00613	CcSEcCtD
Dofetilide—Dermatitis—Vandetanib—thyroid cancer	0.00573	0.00613	CcSEcCtD
Dofetilide—Headache—Vandetanib—thyroid cancer	0.0057	0.00609	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00559	0.00598	CcSEcCtD
Dofetilide—Dyspnoea—Sorafenib—thyroid cancer	0.00547	0.00585	CcSEcCtD
Dofetilide—Nausea—Vandetanib—thyroid cancer	0.00541	0.00578	CcSEcCtD
Dofetilide—Pain—Sorafenib—thyroid cancer	0.00525	0.00561	CcSEcCtD
Dofetilide—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00502	0.00537	CcSEcCtD
Dofetilide—Abdominal pain—Sorafenib—thyroid cancer	0.00485	0.00519	CcSEcCtD
Dofetilide—Cardiac failure—Epirubicin—thyroid cancer	0.00473	0.00506	CcSEcCtD
Dofetilide—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00471	0.00503	CcSEcCtD
Dofetilide—Migraine—Epirubicin—thyroid cancer	0.00454	0.00486	CcSEcCtD
Dofetilide—Asthenia—Sorafenib—thyroid cancer	0.0044	0.00471	CcSEcCtD
Dofetilide—Cardiac arrest—Epirubicin—thyroid cancer	0.00439	0.00469	CcSEcCtD
Dofetilide—Cardiac failure—Doxorubicin—thyroid cancer	0.00438	0.00468	CcSEcCtD
Dofetilide—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00436	0.00466	CcSEcCtD
Dofetilide—Migraine—Doxorubicin—thyroid cancer	0.0042	0.00449	CcSEcCtD
Dofetilide—Diarrhoea—Sorafenib—thyroid cancer	0.0042	0.00449	CcSEcCtD
Dofetilide—Cardiac arrest—Doxorubicin—thyroid cancer	0.00406	0.00434	CcSEcCtD
Dofetilide—Dizziness—Sorafenib—thyroid cancer	0.00406	0.00434	CcSEcCtD
Dofetilide—Influenza—Epirubicin—thyroid cancer	0.00399	0.00426	CcSEcCtD
Dofetilide—KCNK2—lymph node—thyroid cancer	0.00392	0.116	CbGeAlD
Dofetilide—Angina pectoris—Epirubicin—thyroid cancer	0.00389	0.00415	CcSEcCtD
Dofetilide—Rash—Sorafenib—thyroid cancer	0.00387	0.00414	CcSEcCtD
Dofetilide—Dermatitis—Sorafenib—thyroid cancer	0.00387	0.00413	CcSEcCtD
Dofetilide—Headache—Sorafenib—thyroid cancer	0.00385	0.00411	CcSEcCtD
Dofetilide—Influenza—Doxorubicin—thyroid cancer	0.00369	0.00395	CcSEcCtD
Dofetilide—Nausea—Sorafenib—thyroid cancer	0.00365	0.0039	CcSEcCtD
Dofetilide—Angina pectoris—Doxorubicin—thyroid cancer	0.0036	0.00384	CcSEcCtD
Dofetilide—Urinary tract infection—Epirubicin—thyroid cancer	0.00346	0.0037	CcSEcCtD
Dofetilide—Sweating—Epirubicin—thyroid cancer	0.00341	0.00365	CcSEcCtD
Dofetilide—Bradycardia—Epirubicin—thyroid cancer	0.00325	0.00347	CcSEcCtD
Dofetilide—Urinary tract infection—Doxorubicin—thyroid cancer	0.0032	0.00342	CcSEcCtD
Dofetilide—Sweating—Doxorubicin—thyroid cancer	0.00316	0.00337	CcSEcCtD
Dofetilide—Oedema peripheral—Epirubicin—thyroid cancer	0.00315	0.00336	CcSEcCtD
Dofetilide—Bradycardia—Doxorubicin—thyroid cancer	0.00301	0.00322	CcSEcCtD
Dofetilide—Oedema peripheral—Doxorubicin—thyroid cancer	0.00291	0.00311	CcSEcCtD
Dofetilide—Arrhythmia—Epirubicin—thyroid cancer	0.00285	0.00305	CcSEcCtD
Dofetilide—Back pain—Epirubicin—thyroid cancer	0.00269	0.00287	CcSEcCtD
Dofetilide—Arrhythmia—Doxorubicin—thyroid cancer	0.00264	0.00282	CcSEcCtD
Dofetilide—Syncope—Epirubicin—thyroid cancer	0.00249	0.00266	CcSEcCtD
Dofetilide—Back pain—Doxorubicin—thyroid cancer	0.00249	0.00266	CcSEcCtD
Dofetilide—Palpitations—Epirubicin—thyroid cancer	0.00246	0.00263	CcSEcCtD
Dofetilide—Loss of consciousness—Epirubicin—thyroid cancer	0.00244	0.00261	CcSEcCtD
Dofetilide—Cough—Epirubicin—thyroid cancer	0.00243	0.00259	CcSEcCtD
Dofetilide—Hypertension—Epirubicin—thyroid cancer	0.0024	0.00257	CcSEcCtD
Dofetilide—Chest pain—Epirubicin—thyroid cancer	0.00237	0.00253	CcSEcCtD
Dofetilide—Arthralgia—Epirubicin—thyroid cancer	0.00237	0.00253	CcSEcCtD
Dofetilide—Anxiety—Epirubicin—thyroid cancer	0.00236	0.00252	CcSEcCtD
Dofetilide—Syncope—Doxorubicin—thyroid cancer	0.00231	0.00247	CcSEcCtD
Dofetilide—Palpitations—Doxorubicin—thyroid cancer	0.00227	0.00243	CcSEcCtD
Dofetilide—Oedema—Epirubicin—thyroid cancer	0.00227	0.00243	CcSEcCtD
Dofetilide—Loss of consciousness—Doxorubicin—thyroid cancer	0.00226	0.00242	CcSEcCtD
Dofetilide—Cough—Doxorubicin—thyroid cancer	0.00224	0.0024	CcSEcCtD
Dofetilide—Shock—Epirubicin—thyroid cancer	0.00223	0.00239	CcSEcCtD
Dofetilide—Hypertension—Doxorubicin—thyroid cancer	0.00222	0.00237	CcSEcCtD
Dofetilide—Hyperhidrosis—Epirubicin—thyroid cancer	0.00219	0.00234	CcSEcCtD
Dofetilide—Arthralgia—Doxorubicin—thyroid cancer	0.00219	0.00234	CcSEcCtD
Dofetilide—Chest pain—Doxorubicin—thyroid cancer	0.00219	0.00234	CcSEcCtD
Dofetilide—Anxiety—Doxorubicin—thyroid cancer	0.00218	0.00233	CcSEcCtD
Dofetilide—Oedema—Doxorubicin—thyroid cancer	0.0021	0.00224	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00207	0.00221	CcSEcCtD
Dofetilide—Shock—Doxorubicin—thyroid cancer	0.00207	0.00221	CcSEcCtD
Dofetilide—Insomnia—Epirubicin—thyroid cancer	0.00205	0.00219	CcSEcCtD
Dofetilide—Paraesthesia—Epirubicin—thyroid cancer	0.00204	0.00218	CcSEcCtD
Dofetilide—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00203	0.00217	CcSEcCtD
Dofetilide—Dyspnoea—Epirubicin—thyroid cancer	0.00202	0.00216	CcSEcCtD
Dofetilide—Pain—Epirubicin—thyroid cancer	0.00194	0.00207	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00191	0.00204	CcSEcCtD
Dofetilide—Insomnia—Doxorubicin—thyroid cancer	0.0019	0.00203	CcSEcCtD
Dofetilide—Paraesthesia—Doxorubicin—thyroid cancer	0.00188	0.00201	CcSEcCtD
Dofetilide—Dyspnoea—Doxorubicin—thyroid cancer	0.00187	0.002	CcSEcCtD
Dofetilide—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00186	0.00198	CcSEcCtD
Dofetilide—Pain—Doxorubicin—thyroid cancer	0.00179	0.00192	CcSEcCtD
Dofetilide—Abdominal pain—Epirubicin—thyroid cancer	0.00179	0.00192	CcSEcCtD
Dofetilide—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00172	0.00183	CcSEcCtD
Dofetilide—Abdominal pain—Doxorubicin—thyroid cancer	0.00166	0.00177	CcSEcCtD
Dofetilide—Asthenia—Epirubicin—thyroid cancer	0.00163	0.00174	CcSEcCtD
Dofetilide—KCNH2—head—thyroid cancer	0.00156	0.0463	CbGeAlD
Dofetilide—Diarrhoea—Epirubicin—thyroid cancer	0.00155	0.00166	CcSEcCtD
Dofetilide—Asthenia—Doxorubicin—thyroid cancer	0.00151	0.00161	CcSEcCtD
Dofetilide—Dizziness—Epirubicin—thyroid cancer	0.0015	0.0016	CcSEcCtD
Dofetilide—Diarrhoea—Doxorubicin—thyroid cancer	0.00144	0.00154	CcSEcCtD
Dofetilide—Rash—Epirubicin—thyroid cancer	0.00143	0.00153	CcSEcCtD
Dofetilide—Dermatitis—Epirubicin—thyroid cancer	0.00143	0.00153	CcSEcCtD
Dofetilide—Headache—Epirubicin—thyroid cancer	0.00142	0.00152	CcSEcCtD
Dofetilide—Dizziness—Doxorubicin—thyroid cancer	0.00139	0.00148	CcSEcCtD
Dofetilide—Nausea—Epirubicin—thyroid cancer	0.00135	0.00144	CcSEcCtD
Dofetilide—Rash—Doxorubicin—thyroid cancer	0.00132	0.00141	CcSEcCtD
Dofetilide—Dermatitis—Doxorubicin—thyroid cancer	0.00132	0.00141	CcSEcCtD
Dofetilide—Headache—Doxorubicin—thyroid cancer	0.00131	0.00141	CcSEcCtD
Dofetilide—Nausea—Doxorubicin—thyroid cancer	0.00125	0.00133	CcSEcCtD
Dofetilide—KCNH2—lymph node—thyroid cancer	0.00109	0.0324	CbGeAlD
